Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Immunic, Inc. Common Stock (IMUX)

Pharmaceutical Preparations

https://www.imux.com

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

1200 AVENUE OF THE AMERICAS, SUITE 200
NEW YORK, X1

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/17/2014

Market Cap

118,003,490

Shares Outstanding

45,150,000

Weighted SO

45,145,383

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

GBIO --.--%

KRON --.--%

ERAS --.--%

CCCC --.--%

EWTX --.--%

FHTX --.--%

STTK --.--%

GLUE --.--%

KYMR --.--%

Beta

1.7650

Last Div

0.0000

Range

0.945-1.92

Chg

-0.0400

Avg Vol

294296

Mkt Cap

118003490

Exch

NASDAQ

Country

US

Phone

332 255 9818

DCF Diff

0.2920

DCF

1.0230

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.4198

P/FV

2.0868

Div Yield %

0.0000

P/E

-1.3920

PEG

-0.0246

Payout

0.0000

Current Ratio

3.7473

Quick Ratio

3.7473

Cash Ratio

3.5145

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

25274.6491

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-0.0311

ROA

-1.1019

ROE

-1.6982

ROCE

-1.4675

NI/EBT

1.0000

EBT/EBIT

1.0177

EBIT/Rev

0.0000

Debt Ratio

0.0110

D/E

0.0150

LT Debt/Cap

0.0038

Total Debt/Cap

0.0148

Int Coverage

-46.5669

CF/Debt

-75.7476

Equity Multi

1.3605

Rec Turnover

0.0000

Pay Turnover

0.0144

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.7143

FCF/Share

-0.7184

Cash/Share

0.7870

OCF/Sales

0.0000

FCF/OCF

1.0058

CF Coverage

-75.7476

ST Coverage

-101.3151

CapEx Coverage

-172.2357

Div&CapEx Cov

-172.2357

P/BV

2.0868

P/B

2.0868

P/S

0.0000

P/E

-1.3920

P/FCF

-1.6218

P/OCF

-1.8340

P/CF

-1.8340

PEG

-0.0246

P/S

0.0000

EV Multiple

-0.4198

P/FV

2.0868

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation